You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中恆集團(600252.SH):注射用血栓通(凍幹)擬中標中成藥省際聯盟集中帶量採購
格隆匯 12-22 18:08

格隆匯12月22日丨中恆集團(600252.SH)公佈,2021年12月21日,公司參加了由中成藥省際聯盟集採領導小組辦公室(“集採辦公室”)組織的中成藥省際聯盟集中帶量採購的投標工作。根據集採辦公室2021年12月21日發佈的《中成藥省際聯盟集中帶量採購擬中選結果公示》,公司核心子公司廣西梧州製藥(集團)股份有限公司(“梧州製藥”)產品注射用血栓通(凍幹)擬中標此次集中採購。擬中標產品基本情況:

梧州製藥擬中標中成藥省際聯盟集中帶量採購的注射用血栓通(凍幹)(規格:150mg/支*10/盒)2020年度合計銷售額為109826.73萬元,佔公司2020年度營業收入比例為29.87%,其中在鄂、冀、晉、內蒙古、遼、閩、贛、豫、湘、瓊、渝、川、貴、藏、陝、甘、寧、新、新疆兵團(“19省區”)等地區的銷售額為52646.53萬元,佔公司2020年度營業收入比例為14.32%;2021年1-9月合計銷售額為64624.78萬元,佔公司2021年1-9月營業收入比例為24.22%,其中在19省區的銷售額為26335.01萬元,佔公司2021年1-9月營業收入比例為29.87%

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account